Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Henri Roché
Based on 46 articles published since 2009
(Why 46 articles?)
||||
Expertise Level
The expertise of Henri Roché ranks in the
  • Top 0.17%
  • ... of 264,224 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 46 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Roche, Henri   ·   Roché, Henri
Work Locations
Details
Most likely:    Miscellaneous institutions in Toulouse      
2018
  • ICO René Gauducheau, Saint-Herblain, France. Electronic address: · Gustave Roussy, Villejuif, France. · Centre Val D'Aurelle, Montpellier, France. · University Hospitals Leuven and KULeuven, Leuven, Belgium. · Institut Curie, Paris, France. · Centre Eugène Marquis, Rennes, France. · Centre François Baclesse, Caen, France. · Centre Georges-François Leclerc, Dijon, France. · Centre Léon Bérard, Lyon, France. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jean Godinot, Reims, France. · Centre Alexis Vautrin, Nancy, France. · Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · University of AntwerpAZ, Belgium. · Clinique Tivoli, Bordeaux, France. · Polyclinique de Courlancy, Reims, France. · CH de Fleyriat, Bourg en Bresse, France. · Grand Hopital de Charleroi, Charleroi, Belgium. · R&D UNICANCER, UCBG, Paris, France. · Institut Claudius Regaud, IUCT Oncopole, Toulouse, France. · Pubmed 30267987
  • Department of Biopathology, Centre Jean Perrin and EA 4677 ERTICa, Université d'Auvergne, 58 rue Montalembert, 63000, Clermont-Ferrand, France. · Department of Biostatistics, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Institut Curie, Paris, France. · Genomic Health Inc, Redwood City, CA, USA. · University of California, San Francisco, CA, USA. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France. · Department of Pathology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Centre Val d'Aurelle, Montpellier, France. · Department of Pathology, Institut de Cancérologie de l'Ouest (site René Gauducheau), Nantes, Saint-Herblain, France. · Unicancer, Paris, France. · Department of Medical Oncology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Pubmed 29728098
2017
  • Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: · S. Orsola Malpighi Hospital, Bologna, Italy. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Hospital Clínico Universitario de Valencia, Valencia, Spain. · Saitama Cancer Center, Saitama, Japan. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · Curtin Health Innovation Research Institute, Curtin University, Perth, Australia. · University of Pécs, Pécs, Hungary. · Karolinska Institutet and University Hospital, Stockholm, Sweden. · Hospital Sírio Libanês, São Paulo, Brazil. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Northwestern University Feinberg School of Medicine, Chicago, IL. · Memorial Sloan Kettering Cancer Center, New York, NY. · The Medical Oncology Center of Rosebank and Linksfield Park Hospital, Johannesburg, South Africa. · Institut Claudius Régaud, Toulouse, France. · Bayer HealthCare Pharmaceuticals, Whippany, NJ. · The West Clinic, Memphis, TN. · Pubmed 28830796
  • Centre Eugène Marquis, Rue de la Bataille Flandres-Dunkerque - CS 44229, 35042 Rennes Cedex, France. Electronic address: · Centre Georges-François Leclerc, 1 rue Professeur Marion BP 77990, 21079 Dijon, France. Electronic address: · Institut régional du cancer de Montpellier, Parc Euromédecine, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France. Electronic address: · Centre François Baclesse, 3 av du Général Harris, 14000 Caen, France. Electronic address: · Centre Catherine de Sienne, 2 rue Eric Tabarly, 44202 Nantes, France. Electronic address: · Centre Hospitalier, Avenue de l'Hopital, 12000 Rodez, France. Electronic address: · Centre Paul Papin, 15 rue André Boquel, 49000 Angers, France. Electronic address: · Centre Alexis Vautrin, 6 avenue de Bourgogne, 54419 Vandoeuvre-Lès-Nancy, France. Electronic address: · Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. Electronic address: · Institut Curie, Site de Saint-Cloud, 35 rue Dailly, 92210 Saint-Cloud, France. Electronic address: · Institut Sainte-Catherine, 250 Chemin de Baigne Pieds, 84918 Avignon, France. Electronic address: · Centre hospitalier Émile Müller, 20 rue du Docteur Laennec, 68051 Mulhouse, France. Electronic address: · Institut Bergonié, 229 Cours de l'Argonne, 33000 Bordeaux, France. Electronic address: · Institut de cancérologie de l'ouest, Centre René Gauducheau, Boulevard Professeur Jacques Monod, 44805 Saint-Herblain, France. Electronic address: · Centre Jean Perrin, 58 rue Montalembert, 63000 Clermont-Ferrand, France. Electronic address: · Centre Léon Bérard, 28 prom. Léa et Napoléon Bullukian, 69008 Lyon, France. Electronic address: · Centre hospitalier Bretagne-Sud, 5 avenue de Choiseul, 56322 Lorient, France. Electronic address: · Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · R&D Unicancer, UCGB, 101 rue de Tolbiac, 75013 Paris, France. Electronic address: · R&D Unicancer, UCGB, 101 rue de Tolbiac, 75013 Paris, France. Electronic address: · Institut Claudius Regaud, Institut Universitaire Cancer Toulouse-Oncopole, 1 avenue Irèle joliot-Curie, 31059 Toulouse Cedex 9, France. Electronic address: · Pubmed 28501763
  • Institut Claudius-Regaud, institut universitaire du cancer, Toulouse, France · Pubmed 30717583
  • Department of Gynecologic Surgery, IUCT-O, Toulouse, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France. · Department of Radiotherapy, Institut Claudius Regaud, IUCT-O, Toulouse, France. · Department of Biostatistics, Institut Claudius Regaud, IUCT-O, Toulouse, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France. Electronic address: · Pubmed 28042991
  • Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France; Inserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France. Electronic address: · Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy. · Department of Biostatistics, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France; Inserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France; University of Toulouse III, Toulouse France. · Institut Claudius-Regaud, IUCT-Oncopole and EA4553 University of Toulouse III Paul-Sabatier, Toulouse, France. · CHU Limoges, University of Limoges, U850 INSERM, Limoges, France. · LCPMC-A2, ICPM, Département de Chimie, University of Lorraine, Metz, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Inserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France; University of Toulouse III, Toulouse France. Electronic address: · Inserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France; University of Toulouse III, Toulouse France. · Pubmed 27343991
2016
  • Institut Paoli-Calmettes, Medical Oncology Department, Marseille, France. · CRO2, Neuro-Oncology Department, UMRS_911, Marseille, France. · APHM, Marseille, France. · Aix-Marseille University, Marseille, France. · Centre de Recherche en Cancérologie de Marseille, Inserm, Marseille, France. · Centre de Recherche en Cancérologie de Marseille, CNRS, Marseille, France. · Institut Curie & Université Paris Descartes, Medical Oncology Department, Paris, France. · Centre Paul Strauss, Medical Oncology Department, Strasbourg, France. · Centre François Baclesse, Medical Oncology Department, Caen, France. · Centre Antoine Lacassagne, Medical Oncology Department, Nice, France. · Centre René Gauducheau, Medical Oncology Department, Saint-Herblin, France. · APHP-Tenon, APREC, Paris, France. · IUC-UPMC, Sorbonne University, Paris, France. · Hopital Rene Huguenin-Institut Curie, Medical Oncology Department, Saint-Cloud, France. · Institut Claudius Regaud, Medical Oncology Department, Toulouse, France. · Institut Leon Berard, Medical Oncology Department, Lyon, France. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium. · Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Department of Oncology, KU Leuven, Leuven, Belgium. · The University of Texas MD Anderson Cancer Center, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, TX, USA. · Pubmed 26921265
  • INSERM UMR 1037, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France. · Université Toulouse III Paul Sabatier, Toulouse, France. · Institut Claudius Regaud, Toulouse, France. · Institut Curie, PSL Research University, CNRS UMR 176, Orsay, France. · Institut Curie, PSL Research University, CNRS UMR 3348, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 176, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, Orsay, France. · Equipe Labellisée Ligue Contre le Cancer, Paris, France. · Pubmed 26930004
  • Centre de Rhumatologie, Hôpital Pierre-Paul Riquet; · Centre de Rhumatologie, Hôpital Pierre-Paul Riquet. · Institut Universitaire du Cancer Toulouse - Oncopole. · Centre de Rhumatologie, Hôpital Pierre-Paul Riquet, Toulouse, France. · Pubmed 27698110
2015
  • SOLTI Breast Cancer Research Group, Barcelona, Spain. · Medical Oncology, Arnau de Vilanova Hospital, Valencia, Spain. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Medical Oncology, University Clinic Hospital, Valencia, Spain. · Universitary Hospital of Besançon, Besançon, France. · Gustave Roussy Institute, Villejuif, France. · Medical Oncology, Arnau de Vilanova Hospital, Lleida, Spain. · Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Medical Oncology, Sant Joan de Reus Hospital, Reus, Spain. · Institut Bergonié, University of Bordeaux, INSERM U916, Bordeaux, France. · Medical Oncology, Virgen del Rocío Hospital, Sevilla, Spain. · Medical Oncology, 12 de Octubre Hospital, Madrid, Spain. · Institut Claudius Regaud, Toulouse, France. · Medical Oncology, Cáceres Hospital, Cáceres, Spain. · Medical Oncology, Valencia Oncology Institute, Valencia, Spain. · Medical Oncology, Jaen Hospital, Jaen, Spain. · Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of OB&GYN, Breast Center, University of Munich, Munich, Germany. · Sanofi Oncology Division, Cambridge, MA, USA. · Pathology Department, Jean Perrin Center, Clermont-Ferrand, France. · EA 4677 ERTICA University of Auvergne, Clermont-Ferrand, France. · Breast Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 26536871
  • Department of Medical Oncology, Institut du Cancer de Montpellier, 208 avenue des Apothicaires, 34298 Montpellier Cedex 5, France. · Department of Pathology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Methodological and Quality of Life in Oncology Unit, EA 3181, University Hospital of Besançon, 2 place Saint-Jacques, 25000 Besançon, France. · Department of Medical Oncology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Department of Medical Oncology, ICO Centre René Gauducheau, boulevard Jacques Monod, 44805 Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, 114 rue Edouard-Vaillant, 94800 Villejuif, France. · Department of Medical Oncology, Institut Claudius Régaud, 20/24 Rue du Pont Saint Pierre, 31300 Toulouse, France. · R&D UNICANCER, 101 rue de Tolbiac, 75654 Paris, France. · Department of Pathology, Institut Claudius Régaud, 20/24 rue du Pont Saint Pierre, 31300 Toulouse, France. · Pubmed 26260807
  • Institut Curie, Paris, France. Electronic address: · University Hospital Leuven, Leuven, Belgium. Electronic address: · Medical University of Gdańsk, Gdańsk, Poland. Electronic address: · General Hospital Sint-Augustinus, Antwerp, Belgium. Electronic address: · Centre Léon Bérard, Lyon, France. Electronic address: · Helsinki University Central Hospital, Helsinki, Finland. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Institut Paoli-Calmettes, Marseilles, France. Electronic address: · C.R.L.C. Val D'Aurelle, Montpellier, France. Electronic address: · Levine Cancer Institute, Charlotte, NC, USA. Electronic address: · CHU Sart Tilman, Liege, Belgium. Electronic address: · Kidwai Memorial Institute of Oncology, Bangalore, India. Electronic address: · Institut Claudius Régaud, Toulouse, France. Electronic address: · Complejo Hospitalario de Jaén, Jaén, Spain. Electronic address: · European Health Centre Otwock, Warszawa, Poland. Electronic address: · Corporació Sanitària Parc Taulí, Sabadell, Spain. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Pubmed 25747197
  • Institut Curie, Paris, France. Université Paris Descartes, Paris, France. · Centre Paul Strauss, Strasbourg, France. · Centre François Baclesse, Caen, France. · Centre Antoine Lacassagne, Nice, France. · Institut de Cancérologie de l'Ouest-René Gauducheau, Saint Herblain, France. · APHP Tenon, Alliance pour la Recherche en Cancérologie, Paris, France. Institut Universitaire de Cancérologie-Paris VI, Sorbonne Université, Paris, France. · Institut Curie Hôpital René Huguenin, Saint-Cloud, France. · Institut Claudius Regaud, Toulouse, France. · Centre Léon-Bérard, Lyon, France. · Institut Paoli-Calmettes, Marseille, France. Aix-Marseille University, Marseille, France. · Institut Oscar Lambret, Lille, France. · Roche, Boulogne-Billancourt, France. · Institut Curie, Paris, France. · Institut Paoli-Calmettes, Marseille, France. Aix-Marseille University, Marseille, France. · Pubmed 25538259
  • Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France. Electronic address: · Institut de Cancerologie de L Ouest, Saint Herblain, France. · Klinika Onkologii I Radioterapii, Uniwersyteckie, Gdansk, Poland. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Crlcc G. Francois Leclerc, Dijon, France. · Istituto Nazionale Tumori Fondazione Pascale, Napoli, Italy. · Fn Motol, Praha, Czech Republic. · Clinique Armoricaine de Radiologie, Saint Brieuc, France. · Hospital Clinic, Barcelona, Spain. · Bristol-Myers Squibb, Wallingford, CT. · Bristol-Myers Squibb, Rome, Italy. · Institut Claudius Regaud, Toulouse, France. · Pubmed 25218708
  • Institut Claudius Regaud, Toulouse, France. Electronic address: · Quality of Life in Oncology Platform, Besançon, France; Methodological and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France; EA 3181, University of Franche-Comte, Besançon, France. · Aix Marseille Université, Inserm, IRD, UMR_S912, SESSTIM, Marseille, France; APHMDepartment of Public Health, BiosTIC, Hôpital de la Timone, Marseille, France. · Institut Claudius Regaud, Toulouse, France. · Pubmed 25460338
2014
  • Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Tumor Bank, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Pathology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · Département de Biologie et de Pathologie, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31052, France. · Département d'Oncologie Médicale, Institut de Cancérologie de l'Ouest-René Gauducheau, Boulevard Jacques Monod, Saint-Herblain, Nantes, 44805, France. · R&D UNICANCER, UNICANCER, Rue de Tolbiac 101, Paris, Cedex 13 75654, France. · Département d'Oncologie Médicale, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31300, France. · Department of Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, Brussels, 1200, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Pubmed 25416589
  • Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France; Institut National de la Santé et de la Recherche Médicale (INSERM), CRI-866 Faculty of Medicine, Dijon, France; University of Burgundy, Dijon, France. · Biostatistics and Epidemiological Unit, EA 4184, Centre Georges François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medicine and Translational Research Unit, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France; University of Burgundy, Dijon, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Fédération Nationale des Centres de Lutte Contre le Cancer, Paris, France. · EA3920, University of Franche-Comté, Besancon, France. · Methodology and Quality of Life in Oncology Unit, EA 3181, Quality of Life and Cancer Clinical Research Platform, University Hospital, Besancon, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France; Institut National de la Santé et de la Recherche Médicale (INSERM), CRI-866 Faculty of Medicine, Dijon, France; University of Burgundy, Dijon, France. Electronic address: · Pubmed 24315625
2013
  • Institut Claudius-Regaud, département d'oncologie médicale, 20-24, rue du Pont-Saint-Pierre, 31052 Toulouse cedex, France. · Pubmed 24004610
2012
2011
  • Institut Claudius Regaud, 20-24 rue du Saint Pierre, 31052, Toulouse Cedex, France. · Pubmed 21128114
2014
  • Department of dermatology, Institut Claudius Regaud, Institut Universitaire Cancer Toulouse-oncopole, Toulouse, France. · Pubmed 24929675
2013
  • Institut Claudius-Regaud, 20-24 rue du Pont-Saint-Pierre, 31052 Toulouse, France. · Pubmed 23822935
2012
  • Institut Claudius-Regaud, 20-24, rue du Pont-Saint-Pierre, 31052 Toulouse, France. · Pubmed 22641367
Probable:    Universite de Toulouse      
2018
  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France. · Department of Medical Oncology, Institut Curie, Paris, France. · University Hospital Jean Minjoz, INSERM, Besançon, France. · Institut Curie-Hôpital René Huguenin, Saint-Cloud, France. · Institut Claudius-Regaud, IUCT-oncopole, Université Paul-Sabatier, Toulouse, France. · Department of Clinical Research and Innovation, Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France. · Aix Marseille University, INSERM, IRD, SESSTIM, Marseille, France. · Pubmed 29281873
2017
  • Centre Antoine Lacassagne, Nice, France. · CHU de Nîmes, Nîmes, France. · Aix-Marseille University, INSERM UMR S910, GMGF, Marseille, France. · APHM Hôpital Timone, Laboratoire de Génétique Moléculaire, Marseille, France. · Faculté de Pharmacie de Montpellier, Montpellier, France. · Laboratory Genetic Metabolic Diseases, Academic Medical Center, Amsterdam,The Netherlands. · Institut de Cancérologie de l'Ouest, MMS EA 2160, Université de Nantes, Nantes, France. · Institut Claudius-Regaud, CRCT, Université de Toulouse, Inserm, UPS, Toulouse, France. · Institut de Cancérologie de Lorraine, UMR CNRS 7039 CRAN, Université de Lorraine, Nancy, France. · Centre Paul Lamarque, Montpellier, France. · CHU de Besançon, Besançon, France. · Centre Léon Bérard, Lyon, France. · Institut Curie, Paris, France. · Centre Azuréen de Cancérologie, Mougins, France. · CHU de Grenoble, Grenoble, France. · Institut Paoli Calmettes, Marseille, France. · Centre Oscar Lambret, Lille, France. · Polyclinique Nord Aquitaine, Bordeaux, France. · Pubmed 28481884
2016
  • INSERM UMR 1037, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France. · Université Toulouse III Paul Sabatier, Toulouse, France. · Institut Claudius Regaud, Toulouse, France. · Institut Curie, PSL Research University, CNRS UMR 176, Orsay, France. · Institut Curie, PSL Research University, CNRS UMR 3348, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 176, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, Orsay, France. · Equipe Labellisée Ligue Contre le Cancer, Paris, France. · Pubmed 26930004
2014
  • EA4553, Université Paul Sabatier Toulouse III, Toulouse F-31000, France. Electronic address: · EA4553, Université Paul Sabatier Toulouse III, Toulouse F-31000, France; Institut Claudius Regaud, IUCT-O, Laboratoire de pharmacologie, 1 Avenue Joliot-Curie, Toulouse F-31059, France. · Universita Degli Studi Di Genova, Italy. · Département d'Oncologie Médicale, IUCT-O, 1 Avenue Irène Joliot-Curie, 31059 Toulouse, France; Université Paul Sabatier, Toulouse III, Toulouse F-31000, France. · Pubmed 25173109
2013
  • CHU de Toulouse, centre Midi-Pyrénées de pharmacovigilance, de pharmacoépidémiologie et d'informations sur le médicament, service de pharmacologie clinique, 37, allées Jules-Guesde, 31000 Toulouse, France. · Pubmed 23694959
2011
  • INSERM U563, Université Paul Sabatier, Toulouse, France. · Pubmed 21498638
Probable:    Institut Paoli-Calmettes      
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California · the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany · Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France · Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.) · Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.) · and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
2011
  • Department of Molecular Oncology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, 232, Bd Ste-Marguerite, Marseille, 13009, France. · Pubmed 22044691
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 46 total) written by Henri Roché about Breast Neoplasms:

  • UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer. 2018
  • Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation. 2018
  • The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial). 2018
  • Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer. 2018
  • RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer. 2017
  • Optimal duration of adjuvant chemotherapy for high-risk node-negative (N-) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106). 2017
  • Breast cancer diagnostic assessment 2017
  • New advances in DPYD genotype and risk of severe toxicity under capecitabine. 2017
  • External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis. 2017
  • Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study. 2017
Show List of Full Article Records
Google Searches

Learn more about Henri Roché using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Toulouse
Universite de Toulouse
Institut Paoli-Calmettes
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Toulouse
2018
  • ICO René Gauducheau, Saint-Herblain, France. Electronic address: · Gustave Roussy, Villejuif, France. · Centre Val D'Aurelle, Montpellier, France. · University Hospitals Leuven and KULeuven, Leuven, Belgium. · Institut Curie, Paris, France. · Centre Eugène Marquis, Rennes, France. · Centre François Baclesse, Caen, France. · Centre Georges-François Leclerc, Dijon, France. · Centre Léon Bérard, Lyon, France. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jean Godinot, Reims, France. · Centre Alexis Vautrin, Nancy, France. · Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · University of AntwerpAZ, Belgium. · Clinique Tivoli, Bordeaux, France. · Polyclinique de Courlancy, Reims, France. · CH de Fleyriat, Bourg en Bresse, France. · Grand Hopital de Charleroi, Charleroi, Belgium. · R&D UNICANCER, UCBG, Paris, France. · Institut Claudius Regaud, IUCT Oncopole, Toulouse, France. · Pubmed 30267987
  • Department of Biopathology, Centre Jean Perrin and EA 4677 ERTICa, Université d'Auvergne, 58 rue Montalembert, 63000, Clermont-Ferrand, France. · Department of Biostatistics, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Institut Curie, Paris, France. · Genomic Health Inc, Redwood City, CA, USA. · University of California, San Francisco, CA, USA. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France. · Department of Pathology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Centre Val d'Aurelle, Montpellier, France. · Department of Pathology, Institut de Cancérologie de l'Ouest (site René Gauducheau), Nantes, Saint-Herblain, France. · Unicancer, Paris, France. · Department of Medical Oncology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Pubmed 29728098
2017
  • Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: · S. Orsola Malpighi Hospital, Bologna, Italy. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Hospital Clínico Universitario de Valencia, Valencia, Spain. · Saitama Cancer Center, Saitama, Japan. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · Curtin Health Innovation Research Institute, Curtin University, Perth, Australia. · University of Pécs, Pécs, Hungary. · Karolinska Institutet and University Hospital, Stockholm, Sweden. · Hospital Sírio Libanês, São Paulo, Brazil. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Northwestern University Feinberg School of Medicine, Chicago, IL. · Memorial Sloan Kettering Cancer Center, New York, NY. · The Medical Oncology Center of Rosebank and Linksfield Park Hospital, Johannesburg, South Africa. · Institut Claudius Régaud, Toulouse, France. · Bayer HealthCare Pharmaceuticals, Whippany, NJ. · The West Clinic, Memphis, TN. · Pubmed 28830796
  • Centre Eugène Marquis, Rue de la Bataille Flandres-Dunkerque - CS 44229, 35042 Rennes Cedex, France. Electronic address: · Centre Georges-François Leclerc, 1 rue Professeur Marion BP 77990, 21079 Dijon, France. Electronic address: · Institut régional du cancer de Montpellier, Parc Euromédecine, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France. Electronic address: · Centre François Baclesse, 3 av du Général Harris, 14000 Caen, France. Electronic address: · Centre Catherine de Sienne, 2 rue Eric Tabarly, 44202 Nantes, France. Electronic address: · Centre Hospitalier, Avenue de l'Hopital, 12000 Rodez, France. Electronic address: · Centre Paul Papin, 15 rue André Boquel, 49000 Angers, France. Electronic address: · Centre Alexis Vautrin, 6 avenue de Bourgogne, 54419 Vandoeuvre-Lès-Nancy, France. Electronic address: · Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. Electronic address: · Institut Curie, Site de Saint-Cloud, 35 rue Dailly, 92210 Saint-Cloud, France. Electronic address: · Institut Sainte-Catherine, 250 Chemin de Baigne Pieds, 84918 Avignon, France. Electronic address: · Centre hospitalier Émile Müller, 20 rue du Docteur Laennec, 68051 Mulhouse, France. Electronic address: · Institut Bergonié, 229 Cours de l'Argonne, 33000 Bordeaux, France. Electronic address: · Institut de cancérologie de l'ouest, Centre René Gauducheau, Boulevard Professeur Jacques Monod, 44805 Saint-Herblain, France. Electronic address: · Centre Jean Perrin, 58 rue Montalembert, 63000 Clermont-Ferrand, France. Electronic address: · Centre Léon Bérard, 28 prom. Léa et Napoléon Bullukian, 69008 Lyon, France. Electronic address: · Centre hospitalier Bretagne-Sud, 5 avenue de Choiseul, 56322 Lorient, France. Electronic address: · Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · R&D Unicancer, UCGB, 101 rue de Tolbiac, 75013 Paris, France. Electronic address: · R&D Unicancer, UCGB, 101 rue de Tolbiac, 75013 Paris, France. Electronic address: · Institut Claudius Regaud, Institut Universitaire Cancer Toulouse-Oncopole, 1 avenue Irèle joliot-Curie, 31059 Toulouse Cedex 9, France. Electronic address: · Pubmed 28501763
  • Institut Claudius-Regaud, institut universitaire du cancer, Toulouse, France · Pubmed 30717583
  • Department of Gynecologic Surgery, IUCT-O, Toulouse, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France. · Department of Radiotherapy, Institut Claudius Regaud, IUCT-O, Toulouse, France. · Department of Biostatistics, Institut Claudius Regaud, IUCT-O, Toulouse, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France. Electronic address: · Pubmed 28042991
  • Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France; Inserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France. Electronic address: · Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy. · Department of Biostatistics, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France; Inserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France; University of Toulouse III, Toulouse France. · Institut Claudius-Regaud, IUCT-Oncopole and EA4553 University of Toulouse III Paul-Sabatier, Toulouse, France. · CHU Limoges, University of Limoges, U850 INSERM, Limoges, France. · LCPMC-A2, ICPM, Département de Chimie, University of Lorraine, Metz, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Inserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France; University of Toulouse III, Toulouse France. Electronic address: · Inserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France; University of Toulouse III, Toulouse France. · Pubmed 27343991
2016
  • Institut Paoli-Calmettes, Medical Oncology Department, Marseille, France. · CRO2, Neuro-Oncology Department, UMRS_911, Marseille, France. · APHM, Marseille, France. · Aix-Marseille University, Marseille, France. · Centre de Recherche en Cancérologie de Marseille, Inserm, Marseille, France. · Centre de Recherche en Cancérologie de Marseille, CNRS, Marseille, France. · Institut Curie & Université Paris Descartes, Medical Oncology Department, Paris, France. · Centre Paul Strauss, Medical Oncology Department, Strasbourg, France. · Centre François Baclesse, Medical Oncology Department, Caen, France. · Centre Antoine Lacassagne, Medical Oncology Department, Nice, France. · Centre René Gauducheau, Medical Oncology Department, Saint-Herblin, France. · APHP-Tenon, APREC, Paris, France. · IUC-UPMC, Sorbonne University, Paris, France. · Hopital Rene Huguenin-Institut Curie, Medical Oncology Department, Saint-Cloud, France. · Institut Claudius Regaud, Medical Oncology Department, Toulouse, France. · Institut Leon Berard, Medical Oncology Department, Lyon, France. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium. · Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Department of Oncology, KU Leuven, Leuven, Belgium. · The University of Texas MD Anderson Cancer Center, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, TX, USA. · Pubmed 26921265
  • INSERM UMR 1037, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France. · Université Toulouse III Paul Sabatier, Toulouse, France. · Institut Claudius Regaud, Toulouse, France. · Institut Curie, PSL Research University, CNRS UMR 176, Orsay, France. · Institut Curie, PSL Research University, CNRS UMR 3348, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 176, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, Orsay, France. · Equipe Labellisée Ligue Contre le Cancer, Paris, France. · Pubmed 26930004
  • Centre de Rhumatologie, Hôpital Pierre-Paul Riquet; · Centre de Rhumatologie, Hôpital Pierre-Paul Riquet. · Institut Universitaire du Cancer Toulouse - Oncopole. · Centre de Rhumatologie, Hôpital Pierre-Paul Riquet, Toulouse, France. · Pubmed 27698110
2015
  • SOLTI Breast Cancer Research Group, Barcelona, Spain. · Medical Oncology, Arnau de Vilanova Hospital, Valencia, Spain. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Medical Oncology, University Clinic Hospital, Valencia, Spain. · Universitary Hospital of Besançon, Besançon, France. · Gustave Roussy Institute, Villejuif, France. · Medical Oncology, Arnau de Vilanova Hospital, Lleida, Spain. · Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Medical Oncology, Sant Joan de Reus Hospital, Reus, Spain. · Institut Bergonié, University of Bordeaux, INSERM U916, Bordeaux, France. · Medical Oncology, Virgen del Rocío Hospital, Sevilla, Spain. · Medical Oncology, 12 de Octubre Hospital, Madrid, Spain. · Institut Claudius Regaud, Toulouse, France. · Medical Oncology, Cáceres Hospital, Cáceres, Spain. · Medical Oncology, Valencia Oncology Institute, Valencia, Spain. · Medical Oncology, Jaen Hospital, Jaen, Spain. · Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of OB&GYN, Breast Center, University of Munich, Munich, Germany. · Sanofi Oncology Division, Cambridge, MA, USA. · Pathology Department, Jean Perrin Center, Clermont-Ferrand, France. · EA 4677 ERTICA University of Auvergne, Clermont-Ferrand, France. · Breast Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 26536871
  • Department of Medical Oncology, Institut du Cancer de Montpellier, 208 avenue des Apothicaires, 34298 Montpellier Cedex 5, France. · Department of Pathology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Methodological and Quality of Life in Oncology Unit, EA 3181, University Hospital of Besançon, 2 place Saint-Jacques, 25000 Besançon, France. · Department of Medical Oncology, Georges-François Leclerc Cancer Center, 1 rue du Professeur Marion, 21000 Dijon, France. · Department of Medical Oncology, ICO Centre René Gauducheau, boulevard Jacques Monod, 44805 Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, 114 rue Edouard-Vaillant, 94800 Villejuif, France. · Department of Medical Oncology, Institut Claudius Régaud, 20/24 Rue du Pont Saint Pierre, 31300 Toulouse, France. · R&D UNICANCER, 101 rue de Tolbiac, 75654 Paris, France. · Department of Pathology, Institut Claudius Régaud, 20/24 rue du Pont Saint Pierre, 31300 Toulouse, France. · Pubmed 26260807
  • Institut Curie, Paris, France. Electronic address: · University Hospital Leuven, Leuven, Belgium. Electronic address: · Medical University of Gdańsk, Gdańsk, Poland. Electronic address: · General Hospital Sint-Augustinus, Antwerp, Belgium. Electronic address: · Centre Léon Bérard, Lyon, France. Electronic address: · Helsinki University Central Hospital, Helsinki, Finland. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Institut Paoli-Calmettes, Marseilles, France. Electronic address: · C.R.L.C. Val D'Aurelle, Montpellier, France. Electronic address: · Levine Cancer Institute, Charlotte, NC, USA. Electronic address: · CHU Sart Tilman, Liege, Belgium. Electronic address: · Kidwai Memorial Institute of Oncology, Bangalore, India. Electronic address: · Institut Claudius Régaud, Toulouse, France. Electronic address: · Complejo Hospitalario de Jaén, Jaén, Spain. Electronic address: · European Health Centre Otwock, Warszawa, Poland. Electronic address: · Corporació Sanitària Parc Taulí, Sabadell, Spain. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Pubmed 25747197
  • Institut Curie, Paris, France. Université Paris Descartes, Paris, France. · Centre Paul Strauss, Strasbourg, France. · Centre François Baclesse, Caen, France. · Centre Antoine Lacassagne, Nice, France. · Institut de Cancérologie de l'Ouest-René Gauducheau, Saint Herblain, France. · APHP Tenon, Alliance pour la Recherche en Cancérologie, Paris, France. Institut Universitaire de Cancérologie-Paris VI, Sorbonne Université, Paris, France. · Institut Curie Hôpital René Huguenin, Saint-Cloud, France. · Institut Claudius Regaud, Toulouse, France. · Centre Léon-Bérard, Lyon, France. · Institut Paoli-Calmettes, Marseille, France. Aix-Marseille University, Marseille, France. · Institut Oscar Lambret, Lille, France. · Roche, Boulogne-Billancourt, France. · Institut Curie, Paris, France. · Institut Paoli-Calmettes, Marseille, France. Aix-Marseille University, Marseille, France. · Pubmed 25538259
  • Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France. Electronic address: · Institut de Cancerologie de L Ouest, Saint Herblain, France. · Klinika Onkologii I Radioterapii, Uniwersyteckie, Gdansk, Poland. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Crlcc G. Francois Leclerc, Dijon, France. · Istituto Nazionale Tumori Fondazione Pascale, Napoli, Italy. · Fn Motol, Praha, Czech Republic. · Clinique Armoricaine de Radiologie, Saint Brieuc, France. · Hospital Clinic, Barcelona, Spain. · Bristol-Myers Squibb, Wallingford, CT. · Bristol-Myers Squibb, Rome, Italy. · Institut Claudius Regaud, Toulouse, France. · Pubmed 25218708
  • Institut Claudius Regaud, Toulouse, France. Electronic address: · Quality of Life in Oncology Platform, Besançon, France; Methodological and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France; EA 3181, University of Franche-Comte, Besançon, France. · Aix Marseille Université, Inserm, IRD, UMR_S912, SESSTIM, Marseille, France; APHMDepartment of Public Health, BiosTIC, Hôpital de la Timone, Marseille, France. · Institut Claudius Regaud, Toulouse, France. · Pubmed 25460338
2014
  • Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Laboratory of Translational Oncology, Institute of Pathology and Genetics/ Grand Hôpital de Charleroi, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Tumor Bank, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Pathology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · Department of Molecular Biology, Institute of Pathology and Genetics, Avenue Georges Lemaître 25, Gosselies, 6041, Belgium. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · MdxHealth Inc 15279 Alton Parkway, Suite 100, Irvine, CA, 92618, USA. · Département de Biologie et de Pathologie, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31052, France. · Département d'Oncologie Médicale, Institut de Cancérologie de l'Ouest-René Gauducheau, Boulevard Jacques Monod, Saint-Herblain, Nantes, 44805, France. · R&D UNICANCER, UNICANCER, Rue de Tolbiac 101, Paris, Cedex 13 75654, France. · Département d'Oncologie Médicale, Institut Claudius Regaud, 20-24, Rue Pont St Pierre, Toulouse, 31300, France. · Department of Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, Brussels, 1200, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Service of Oncology-Hematology, Grand Hôpital de Charleroi, Grand'Rue, 3, Charleroi, 6000, Belgium. · Pubmed 25416589
  • Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France; Institut National de la Santé et de la Recherche Médicale (INSERM), CRI-866 Faculty of Medicine, Dijon, France; University of Burgundy, Dijon, France. · Biostatistics and Epidemiological Unit, EA 4184, Centre Georges François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medicine and Translational Research Unit, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France; University of Burgundy, Dijon, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Fédération Nationale des Centres de Lutte Contre le Cancer, Paris, France. · EA3920, University of Franche-Comté, Besancon, France. · Methodology and Quality of Life in Oncology Unit, EA 3181, Quality of Life and Cancer Clinical Research Platform, University Hospital, Besancon, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France; Institut National de la Santé et de la Recherche Médicale (INSERM), CRI-866 Faculty of Medicine, Dijon, France; University of Burgundy, Dijon, France. Electronic address: · Pubmed 24315625
2013
  • Institut Claudius-Regaud, département d'oncologie médicale, 20-24, rue du Pont-Saint-Pierre, 31052 Toulouse cedex, France. · Pubmed 24004610
2012
2011
  • Institut Claudius Regaud, 20-24 rue du Saint Pierre, 31052, Toulouse Cedex, France. · Pubmed 21128114
2014
  • Department of dermatology, Institut Claudius Regaud, Institut Universitaire Cancer Toulouse-oncopole, Toulouse, France. · Pubmed 24929675
2013
  • Institut Claudius-Regaud, 20-24 rue du Pont-Saint-Pierre, 31052 Toulouse, France. · Pubmed 23822935
2012
  • Institut Claudius-Regaud, 20-24, rue du Pont-Saint-Pierre, 31052 Toulouse, France. · Pubmed 22641367
Universite de Toulouse
2018
  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France. · Department of Medical Oncology, Institut Curie, Paris, France. · University Hospital Jean Minjoz, INSERM, Besançon, France. · Institut Curie-Hôpital René Huguenin, Saint-Cloud, France. · Institut Claudius-Regaud, IUCT-oncopole, Université Paul-Sabatier, Toulouse, France. · Department of Clinical Research and Innovation, Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France. · Aix Marseille University, INSERM, IRD, SESSTIM, Marseille, France. · Pubmed 29281873
2017
  • Centre Antoine Lacassagne, Nice, France. · CHU de Nîmes, Nîmes, France. · Aix-Marseille University, INSERM UMR S910, GMGF, Marseille, France. · APHM Hôpital Timone, Laboratoire de Génétique Moléculaire, Marseille, France. · Faculté de Pharmacie de Montpellier, Montpellier, France. · Laboratory Genetic Metabolic Diseases, Academic Medical Center, Amsterdam,The Netherlands. · Institut de Cancérologie de l'Ouest, MMS EA 2160, Université de Nantes, Nantes, France. · Institut Claudius-Regaud, CRCT, Université de Toulouse, Inserm, UPS, Toulouse, France. · Institut de Cancérologie de Lorraine, UMR CNRS 7039 CRAN, Université de Lorraine, Nancy, France. · Centre Paul Lamarque, Montpellier, France. · CHU de Besançon, Besançon, France. · Centre Léon Bérard, Lyon, France. · Institut Curie, Paris, France. · Centre Azuréen de Cancérologie, Mougins, France. · CHU de Grenoble, Grenoble, France. · Institut Paoli Calmettes, Marseille, France. · Centre Oscar Lambret, Lille, France. · Polyclinique Nord Aquitaine, Bordeaux, France. · Pubmed 28481884
2016
  • INSERM UMR 1037, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France. · Université Toulouse III Paul Sabatier, Toulouse, France. · Institut Claudius Regaud, Toulouse, France. · Institut Curie, PSL Research University, CNRS UMR 176, Orsay, France. · Institut Curie, PSL Research University, CNRS UMR 3348, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 176, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, Orsay, France. · Equipe Labellisée Ligue Contre le Cancer, Paris, France. · Pubmed 26930004
2014
  • EA4553, Université Paul Sabatier Toulouse III, Toulouse F-31000, France. Electronic address: · EA4553, Université Paul Sabatier Toulouse III, Toulouse F-31000, France; Institut Claudius Regaud, IUCT-O, Laboratoire de pharmacologie, 1 Avenue Joliot-Curie, Toulouse F-31059, France. · Universita Degli Studi Di Genova, Italy. · Département d'Oncologie Médicale, IUCT-O, 1 Avenue Irène Joliot-Curie, 31059 Toulouse, France; Université Paul Sabatier, Toulouse III, Toulouse F-31000, France. · Pubmed 25173109
2013
  • CHU de Toulouse, centre Midi-Pyrénées de pharmacovigilance, de pharmacoépidémiologie et d'informations sur le médicament, service de pharmacologie clinique, 37, allées Jules-Guesde, 31000 Toulouse, France. · Pubmed 23694959
2011
  • INSERM U563, Université Paul Sabatier, Toulouse, France. · Pubmed 21498638
Institut Paoli-Calmettes
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California · the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany · Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France · Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.) · Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.) · and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
2011
  • Department of Molecular Oncology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, 232, Bd Ste-Marguerite, Marseille, 13009, France. · Pubmed 22044691
INSERM France
2017
  • Centre Antoine Lacassagne, Nice, France. · CHU de Nîmes, Nîmes, France. · Aix-Marseille University, INSERM UMR S910, GMGF, Marseille, France. · APHM Hôpital Timone, Laboratoire de Génétique Moléculaire, Marseille, France. · Faculté de Pharmacie de Montpellier, Montpellier, France. · Laboratory Genetic Metabolic Diseases, Academic Medical Center, Amsterdam,The Netherlands. · Institut de Cancérologie de l'Ouest, MMS EA 2160, Université de Nantes, Nantes, France. · Institut Claudius-Regaud, CRCT, Université de Toulouse, Inserm, UPS, Toulouse, France. · Institut de Cancérologie de Lorraine, UMR CNRS 7039 CRAN, Université de Lorraine, Nancy, France. · Centre Paul Lamarque, Montpellier, France. · CHU de Besançon, Besançon, France. · Centre Léon Bérard, Lyon, France. · Institut Curie, Paris, France. · Centre Azuréen de Cancérologie, Mougins, France. · CHU de Grenoble, Grenoble, France. · Institut Paoli Calmettes, Marseille, France. · Centre Oscar Lambret, Lille, France. · Polyclinique Nord Aquitaine, Bordeaux, France. · Pubmed 28481884
2016
  • INSERM UMR 1037, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France. · Université Toulouse III Paul Sabatier, Toulouse, France. · Institut Claudius Regaud, Toulouse, France. · Institut Curie, PSL Research University, CNRS UMR 176, Orsay, France. · Institut Curie, PSL Research University, CNRS UMR 3348, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 176, Orsay, France. · Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, Orsay, France. · Equipe Labellisée Ligue Contre le Cancer, Paris, France. · Pubmed 26930004
2011
  • Department of Molecular Oncology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, 232, Bd Ste-Marguerite, Marseille, 13009, France. · Pubmed 22044691
  • INSERM U563, Université Paul Sabatier, Toulouse, France. · Pubmed 21498638
  • Inserm, UMR 912 "Economic & Social Sciences, Health Systems & Societies", IRD, 13000, Marseilles, Cedex 9, France, · Pubmed 21061059
15 Other Locations Show
Yearly article counts 04637458900
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.